0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Vestibular Toxicity of Gentamicin in the Presence of Renal Disease

Franklin D. Schwartz, MD
Arch Intern Med. 1978;138(11):1612-1613. doi:10.1001/archinte.1978.03630360010007.
Text Size: A A A
Published online

A minoglycoside antibiotics are widely used in treatment of serious Gram-negative infections. In addition, they are used in combination with penicillins to treat enterococcal infections and with penicillinase-resistant penicillins or cephalosporins for staphylococcal infections.

Currently available aminoglycoside antibiotics include streptomycin, neomycin, paromomycin, gentamicin, tobramycin, and amikacin. Several newer compounds are still under investigation.

Unlike other antibiotics, such as penicillin, therapeutic levels of the aminoglycosides are perilously close to toxic levels—the therapeutic index is small. Further, selection of the optimal dosage is difficult because of considerable variation from subject to subject, both in peak blood levels produced by a given dose and also in serum half-life of the antibiotic.1-3

This problem is magnified for patients with renal insufficiency and even further exaggerated for those receiving long-term hemodialysis. A number of approaches have been proposed for dosage determination in the presence of reduced renal function. Most utilize various forms of equations

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();